抗tnf -α治疗创伤后应激障碍共病性疼痛的潜在治疗方法

Q4 Medicine

Douleur Et Analgesie Pub Date : 2022-01-01 DOI:10.3166/dea-2022-0193

H.M.C. Illouz

{"title":"抗tnf -α治疗创伤后应激障碍共病性疼痛的潜在治疗方法","authors":"H.M.C. Illouz","doi":"10.3166/dea-2022-0193","DOIUrl":null,"url":null,"abstract":"Post-traumatic stress disorder (PTSD) is a psychiatric disorder that occurs after exposure to a traumatic event. Chronic pain is one of the most frequent comorbidities for patients with PTSD and higher levels of the proinflammatory cytokine tumor necrosis factor α (TNF-α) have been detected in these patients. In a recent study, Dib et al (2021) used the single prolonged stress (SPS) animal model of PTSD and blocked TNF-α with either thalidomide or anti-TNF-α antibody. This way, the authors prevented mechanical allodynia and thermal hyperalgesia in SPS-rats.","PeriodicalId":11303,"journal":{"name":"Douleur Et Analgesie","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-TNF-α Therapy as a Potential Treatment for Comorbid Pain in Post-traumatic Stress Disorder\",\"authors\":\"H.M.C. Illouz\",\"doi\":\"10.3166/dea-2022-0193\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Post-traumatic stress disorder (PTSD) is a psychiatric disorder that occurs after exposure to a traumatic event. Chronic pain is one of the most frequent comorbidities for patients with PTSD and higher levels of the proinflammatory cytokine tumor necrosis factor α (TNF-α) have been detected in these patients. In a recent study, Dib et al (2021) used the single prolonged stress (SPS) animal model of PTSD and blocked TNF-α with either thalidomide or anti-TNF-α antibody. This way, the authors prevented mechanical allodynia and thermal hyperalgesia in SPS-rats.\",\"PeriodicalId\":11303,\"journal\":{\"name\":\"Douleur Et Analgesie\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Douleur Et Analgesie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3166/dea-2022-0193\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Douleur Et Analgesie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3166/dea-2022-0193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

创伤后应激障碍(PTSD)是一种暴露于创伤性事件后发生的精神障碍。慢性疼痛是创伤后应激障碍患者最常见的合并症之一，在这些患者中检测到较高水平的促炎细胞因子肿瘤坏死因子α (TNF-α)。在最近的一项研究中，Dib等(2021)使用创伤后应激障碍的单次延长应激(SPS)动物模型，用沙利度胺或抗TNF-α抗体阻断TNF-α。通过这种方法，作者阻止了sps大鼠的机械异常性疼痛和热痛觉过敏。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Anti-TNF-α Therapy as a Potential Treatment for Comorbid Pain in Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a psychiatric disorder that occurs after exposure to a traumatic event. Chronic pain is one of the most frequent comorbidities for patients with PTSD and higher levels of the proinflammatory cytokine tumor necrosis factor α (TNF-α) have been detected in these patients. In a recent study, Dib et al (2021) used the single prolonged stress (SPS) animal model of PTSD and blocked TNF-α with either thalidomide or anti-TNF-α antibody. This way, the authors prevented mechanical allodynia and thermal hyperalgesia in SPS-rats.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Douleur Et Analgesie 医学-临床神经学

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Douleur et Analgésie, première revue internationale francophone consacrée à la douleur, a été créée en 1988. De par la qualité scientifique et l’indépendance de ses publications, ce trimestriel a reçu d’emblée un accueil favorable auprès des chercheurs et cliniciens spécialisés dans le domaine. Á l’occasion de la reprise de la revue en 2006 par les Éditions Springer, le comité éditorial a souhaité s’ouvrir davantage à la francophonie, y compris nord américaine, pour mieux partager les connaissances et renforcer la valeur scientifique de la revue.